Global Cell and Gene Therapy Market Growth (Status and Outlook) 2020-2025

Publisher Name :
Date: 16-Jul-2020
No. of pages: 134

According to this study, over the next five years the Cell and Gene Therapy market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cell and Gene Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Cell and Gene Therapy, covering the supply chain analysis, impact assessment to the Cell and Gene Therapy market size growth rate in several scenarios, and the measures to be undertaken by Cell and Gene Therapy companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.

- Rare Diseases

- Oncology

- Hematology

- Cardiovascular

- Ophthalmology

- Neurology

- Other Therapeutic Classes

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.

- Pharmaceutical and Biotechnology Companies

- Research and Academic Institutions

- Contract Research Organizations (CROs)

- Hospital

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Amgen Inc.

- Organogenesis Holdings Inc.

- bluebird bio, Inc.

- Fibrocell Science, Inc.

- Human Stem Cells Institute

- Dendreon Pharmaceuticals LLC.

- Novartis AG

- Kite Pharma, Inc.

- Orchard Therapeutics plc.

- Kolon TissueGene, Inc.

- Vericel Corporation

- ViroMed Co., Ltd.

- Pfizer, Inc.

- Sibiono GeneTech Co. Ltd.,

- Shanghai Sunway Biotech Co., Ltd.,

- Spark Therapeutics, Inc.

- RENOVA THERAPEUTICS

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Cell and Gene Therapy market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Cell and Gene Therapy market by identifying its various subsegments.

- Focuses on the key global Cell and Gene Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Cell and Gene Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Cell and Gene Therapy submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Cell and Gene Therapy Market Growth (Status and Outlook) 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Market Size 2015-2025
2.1.2 Cell and Gene Therapy Market Size CAGR by Region
2.2 Cell and Gene Therapy Segment by Type
2.2.1 Rare Diseases
2.2.2 Rare Diseases
2.2.3 Hematology
2.2.4 Cardiovascular
2.2.5 Ophthalmology
2.2.6 Neurology
2.2.7 Other Therapeutic Classes
2.3 Cell and Gene Therapy Market Size by Type
2.3.1 Global Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
2.3.2 Global Cell and Gene Therapy Market Size Growth Rate by Type (2015-2020)
2.4 Cell and Gene Therapy Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Research and Academic Institutions
2.4.3 Contract Research Organizations (CROs)
2.4.4 Hospital
2.4.5 Others
2.5 Cell and Gene Therapy Market Size by Application
2.5.1 Global Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
2.5.2 Global Cell and Gene Therapy Market Size Growth Rate by Application (2015-2020)

3 Global Cell and Gene Therapy by Players
3.1 Global Cell and Gene Therapy Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Market Size by Players (2018-2020)
3.1.2 Global Cell and Gene Therapy Market Size Market Share by Players (2018-2020)
3.2 Global Cell and Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Cell and Gene Therapy by Regions
4.1 Cell and Gene Therapy Market Size by Regions
4.2 Americas Cell and Gene Therapy Market Size Growth
4.3 APAC Cell and Gene Therapy Market Size Growth
4.4 Europe Cell and Gene Therapy Market Size Growth
4.5 Middle East & Africa Cell and Gene Therapy Market Size Growth

5 Americas
5.1 Americas Cell and Gene Therapy Market Size by Countries
5.2 Americas Cell and Gene Therapy Market Size by Type
5.3 Americas Cell and Gene Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Cell and Gene Therapy Market Size by Regions
6.2 APAC Cell and Gene Therapy Market Size by Type
6.3 APAC Cell and Gene Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Cell and Gene Therapy by Countries
7.2 Europe Cell and Gene Therapy Market Size by Type
7.3 Europe Cell and Gene Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Cell and Gene Therapy by Countries
8.2 Middle East & Africa Cell and Gene Therapy Market Size by Type
8.3 Middle East & Africa Cell and Gene Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Cell and Gene Therapy Market Forecast
10.1 Global Cell and Gene Therapy Market Size Forecast (2021-2025)
10.2 Global Cell and Gene Therapy Forecast by Regions
10.2.1 Global Cell and Gene Therapy Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Cell and Gene Therapy Forecast by Type
10.8 Global Cell and Gene Therapy Forecast by Application

11 Key Players Analysis
11.1 Amgen Inc.
11.1.1 Company Details
11.1.2 Cell and Gene Therapy Product Offered
11.1.3 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Amgen Inc. News
11.2 Organogenesis Holdings Inc.
11.2.1 Company Details
11.2.2 Cell and Gene Therapy Product Offered
11.2.3 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Organogenesis Holdings Inc. News
11.3 bluebird bio, Inc.
11.3.1 Company Details
11.3.2 Cell and Gene Therapy Product Offered
11.3.3 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 bluebird bio, Inc. News
11.4 Fibrocell Science, Inc.
11.4.1 Company Details
11.4.2 Cell and Gene Therapy Product Offered
11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Fibrocell Science, Inc. News
11.5 Human Stem Cells Institute
11.5.1 Company Details
11.5.2 Cell and Gene Therapy Product Offered
11.5.3 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Human Stem Cells Institute News
11.6 Dendreon Pharmaceuticals LLC.
11.6.1 Company Details
11.6.2 Cell and Gene Therapy Product Offered
11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Dendreon Pharmaceuticals LLC. News
11.7 Novartis AG
11.7.1 Company Details
11.7.2 Cell and Gene Therapy Product Offered
11.7.3 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Novartis AG News
11.8 Kite Pharma, Inc.
11.8.1 Company Details
11.8.2 Cell and Gene Therapy Product Offered
11.8.3 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Kite Pharma, Inc. News
11.9 Orchard Therapeutics plc.
11.9.1 Company Details
11.9.2 Cell and Gene Therapy Product Offered
11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Orchard Therapeutics plc. News
11.10 Kolon TissueGene, Inc.
11.10.1 Company Details
11.10.2 Cell and Gene Therapy Product Offered
11.10.3 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Kolon TissueGene, Inc. News
11.11 Vericel Corporation
11.12 ViroMed Co., Ltd.
11.13 Pfizer, Inc.
11.14 Sibiono GeneTech Co. Ltd.,
11.15 Shanghai Sunway Biotech Co., Ltd.,
11.16 Spark Therapeutics, Inc.
11.17 RENOVA THERAPEUTICS

12 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Cell and Gene Therapy Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Rare Diseases
Table 5. Major Players of Oncology
Table 6. Major Players of Hematology
Table 7. Major Players of Cardiovascular
Table 8. Major Players of Ophthalmology
Table 9. Major Players of Neurology
Table 10. Major Players of Other Therapeutic Classes
Table 11. Cell and Gene Therapy Market Size by Type (2014-2019) ($ Millions)
Table 12. Global Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 13. Global Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 14. Global Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 15. Global Cell and Gene Therapy Revenue by Players (2018-2020) ($ Millions)
Table 16. Global Cell and Gene Therapy Revenue Market Share by Players (2018-2020)
Table 17. Global Cell and Gene Therapy Key Players Head office and Products Offered
Table 18. Cell and Gene Therapy Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Cell and Gene Therapy Market Size by Regions 2015-2020 ($ Millions)
Table 22. Global Cell and Gene Therapy Market Size Market Share by Regions 2015-2020
Table 23. Americas Cell and Gene Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 24. Americas Cell and Gene Therapy Market Size Market Share by Countries (2015-2020)
Table 25. Americas Cell and Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 26. Americas Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 27. Americas Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 28. Americas Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 29. APAC Cell and Gene Therapy Market Size by Regions (2015-2020) ($ Millions)
Table 30. APAC Cell and Gene Therapy Market Size Market Share by Regions (2015-2020)
Table 31. APAC Cell and Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 32. APAC Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 33. APAC Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 34. APAC Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 35. Europe Cell and Gene Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 36. Europe Cell and Gene Therapy Market Size Market Share by Countries (2015-2020)
Table 37. Europe Cell and Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 38. Europe Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 39. Europe Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 40. Europe Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 41. Middle East & Africa Cell and Gene Therapy Market Size by Countries (2015-2020) ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Countries (2015-2020)
Table 43. Middle East & Africa Cell and Gene Therapy Market Size by Type (2015-2020) ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Table 45. Middle East & Africa Cell and Gene Therapy Market Size by Application (2015-2020) ($ Millions)
Table 46. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2015-2020)
Table 47. Key and Potential Regions of Cell and Gene Therapy
Table 48. Key Application and Potential Industries of Cell and Gene Therapy
Table 49. Key Challenges of Cell and Gene Therapy
Table 50. Key Trends of Cell and Gene Therapy
Table 51. Global Cell and Gene Therapy Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 52. Global Cell and Gene Therapy Market Size Market Share Forecast by Regions
Table 53. Global Cell and Gene Therapy Market Size Forecast by Type (2021-2025) ($ Millions)
Table 54. Global Cell and Gene Therapy Market Size Market Share Forecast by Type (2021-2025)
Table 55. Global Cell and Gene Therapy Market Size Forecast by Application (2021-2025) ($ Millions)
Table 56. Global Cell and Gene Therapy Market Size Market Share Forecast by Application (2021-2025)
Table 57. Amgen Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 58. Amgen Inc. Cell and Gene Therapy Product Offered
Table 59. Amgen Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 60. Amgen Inc. Main Business
Table 61. Amgen Inc. Latest Developments
Table 62. Organogenesis Holdings Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 63. Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered
Table 64. Organogenesis Holdings Inc. Main Business
Table 65. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 66. Organogenesis Holdings Inc. Latest Developments
Table 67. bluebird bio, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 68. bluebird bio, Inc. Cell and Gene Therapy Product Offered
Table 69. bluebird bio, Inc. Main Business
Table 70. bluebird bio, Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 71. bluebird bio, Inc. Latest Developments
Table 72. Fibrocell Science, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 73. Fibrocell Science, Inc. Cell and Gene Therapy Product Offered
Table 74. Fibrocell Science, Inc. Main Business
Table 75. Fibrocell Science, Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 76. Fibrocell Science, Inc. Latest Developments
Table 77. Human Stem Cells Institute Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 78. Human Stem Cells Institute Cell and Gene Therapy Product Offered
Table 79. Human Stem Cells Institute Main Business
Table 80. Human Stem Cells Institute Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 81. Human Stem Cells Institute Latest Developments
Table 82. Dendreon Pharmaceuticals LLC. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 83. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
Table 84. Dendreon Pharmaceuticals LLC. Main Business
Table 85. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 86. Dendreon Pharmaceuticals LLC. Latest Developments
Table 87. Novartis AG Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 88. Novartis AG Cell and Gene Therapy Product Offered
Table 89. Novartis AG Main Business
Table 90. Novartis AG Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 91. Novartis AG Latest Developments
Table 92. Kite Pharma, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 93. Kite Pharma, Inc. Cell and Gene Therapy Product Offered
Table 94. Kite Pharma, Inc. Main Business
Table 95. Kite Pharma, Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 96. Kite Pharma, Inc. Latest Developments
Table 97. Orchard Therapeutics plc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 98. Orchard Therapeutics plc. Cell and Gene Therapy Product Offered
Table 99. Orchard Therapeutics plc. Main Business
Table 100. Orchard Therapeutics plc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 101. Orchard Therapeutics plc. Latest Developments
Table 102. Kolon TissueGene, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 103. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
Table 104. Kolon TissueGene, Inc. Main Business
Table 105. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue and Gross Margin (2018-2020E)
Table 106. Kolon TissueGene, Inc. Latest Developments
Table 107. Vericel Corporation Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 108. ViroMed Co., Ltd. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 109. Pfizer, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 110. Sibiono GeneTech Co. Ltd., Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 111. Shanghai Sunway Biotech Co., Ltd., Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 112. Spark Therapeutics, Inc. Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors
Table 113. RENOVA THERAPEUTICS Details, Company Total Revenue (in $ million), Head Office, Cell and Gene Therapy Major Market Areas and Its Competitors

List of Figures

Figure 1. Cell and Gene Therapy Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Cell and Gene Therapy Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Cell and Gene Therapy Market Size Market Share by Type (2015-2020)
Figure 5. Global Rare Diseases Market Size Growth Rate
Figure 6. Global Oncology Market Size Growth Rate
Figure 7. Global Hematology Market Size Growth Rate
Figure 8. Global Cardiovascular Market Size Growth Rate
Figure 9. Global Ophthalmology Market Size Growth Rate
Figure 10. Global Neurology Market Size Growth Rate
Figure 11. Global Other Therapeutic Classes Market Size Growth Rate
Figure 12. Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies
Figure 13. Global Cell and Gene Therapy Market: Pharmaceutical and Biotechnology Companies (2015-2020) ($ Millions)
Figure 14. Cell and Gene Therapy in Research and Academic Institutions
Figure 15. Global Cell and Gene Therapy Market: Research and Academic Institutions (2015-2020) ($ Millions)
Figure 16. Cell and Gene Therapy in Contract Research Organizations (CROs)
Figure 17. Global Cell and Gene Therapy Market: Contract Research Organizations (CROs) (2015-2020) ($ Millions)
Figure 18. Global Contract Research Organizations (CROs) YoY Growth ($ Millions)
Figure 19. Cell and Gene Therapy in Hospital
Figure 20. Global Cell and Gene Therapy Market: Hospital (2015-2020) ($ Millions)
Figure 21. Global Hospital YoY Growth ($ Millions)
Figure 22. Cell and Gene Therapy in Others
Figure 23. Global Cell and Gene Therapy Market: Others (2015-2020) ($ Millions)
Figure 24. Global Others YoY Growth ($ Millions)
Figure 25. Global Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 26. Global Cell and Gene Therapy Market Size Market Share by Regions 2015-2020
Figure 27. Americas Cell and Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 28. APAC Cell and Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 29. Europe Cell and Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 30. Middle East & Africa Cell and Gene Therapy Market Size 2015-2020 ($ Millions)
Figure 31. Americas Cell and Gene Therapy Market Size Market Share by Countries in 2019
Figure 32. Americas Cell and Gene Therapy Market Size Market Share by Type in 2019
Figure 33. Americas Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 34. United States Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 35. Canada Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 36. Mexico Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 37. APAC Cell and Gene Therapy Market Size Market Share by Regions in 2019
Figure 38. APAC Cell and Gene Therapy Market Size Market Share by Type in 2019
Figure 39. APAC Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 40. China Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 41. Japan Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 42. Korea Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 43. Southeast Asia Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 44. India Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 45. Australia Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 46. Europe Cell and Gene Therapy Market Size Market Share by Countries in 2019
Figure 47. Europe Cell and Gene Therapy Market Size Market Share by Type in 2019
Figure 48. Europe Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 49. Germany Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 50. France Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 51. UK Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 52. Italy Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 53. Russia Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 54. Spain Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 55. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Countries in 2019
Figure 56. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type in 2019
Figure 57. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application in 2019
Figure 58. Egypt Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 59. South Africa Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 60. Israel Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 61. Turkey Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 62. GCC Countries Cell and Gene Therapy Market Size Growth 2015-2020 ($ Millions)
Figure 63. Global Cell and Gene Therapy arket Size Forecast (2021-2025) ($ Millions)
Figure 64. Americas Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 65. APAC Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 66. Europe Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 67. Middle East & Africa Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 68. United States Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 69. Canada Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 70. Mexico Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 71. Brazil Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 72. China Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 73. Japan Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 74. Korea Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 75. Southeast Asia Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 76. India Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 77. Australia Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 78. Germany Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 79. France Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 80. UK Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 81. Italy Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 82. Russia Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 83. Spain Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 84. Egypt Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 85. South Africa Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 86. Israel Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 87. Turkey Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
Figure 88. GCC Countries Cell and Gene Therapy Market Size 2021-2025 ($ Millions)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs